We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
How to use a quasi-experimental study to evaluate your digital health product.
How to use an interrupted time series to evaluate your digital health product.
Get help to classify textiles and which headings and codes to use.
Helping public health practitioners conducting evaluations – using outcome evaluations to find out if an intervention works.
How to use a before-and-after study to evaluate your digital health product.
How to use a crossover randomised controlled trial to evaluate your digital health product.
Find registered designs in the UK
To protect your design outside of the UK, you usually need to apply in each country you want protection in.
The UK government's design principles and examples of how they've been used.
How to use a factorial randomised controlled trial to evaluate your digital health product.
How to use a combination of quantitative and qualitative data to evaluate your digital health product.
Guidance for manufacturers, importers and distributors.
Resources to help local commissioners achieve value for money by estimating the return on investment (ROI) and cost-effectiveness of public health programmes.
This page provides details about DSIT's portfolio of AI assurance techniques and how to use it.
How to tax a beneficial loan arrangement for a director or employee.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
This playbook explains how we use social media at GDS. In it, we share our best practice, what we've learned and what we're planning to do.
Evaluation and case studies from the first phase of our design code pilots.
Get certified or uncertified copies of your patent, trade mark or design registration documents to prove that you have intellectual property rights.
Information for manufacturers of medical devices about reporting adverse incidents and field safety corrective actions to the MHRA.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).